All ADSs to be sold in the proposed offering will be offered by Legend Biotech. Morgan, Jefferies and Evercore ISI are serving as joint book-running managers for the offering. Legend Biotech also intends to grant the underwriters a 30-day option to purchase up to an additional $37.
💼 Business Developments:
No specific business developments reported in this filing.
🌍 Legend Biotech (LEGN) - Form 6-K Filing
Filing Date: 2022-07-25
Accepted: 2022-07-25 16:07:55
Event Type: Other Event
Event Details:
💼 Business Developments:
No specific business developments reported in this filing.
📞 Contact Information: